Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma.
Tendas
Andrea
A
Cupelli
Luca
L
Dentamaro
Teresa
T
Scaramucci
Laura
L
Palumbo
Roberto
R
Niscola
Pasquale
P
Giovannini
Marco
M
Piccioni
Daniela
D
Perrotti
Alessio Pio
AP
de Fabritiis
Paolo
P
D000368:Aged; D003131:Combined Modality Therapy / Q000379:methods; D004359:Drug Therapy, Combination; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D006435:Renal Dialysis; D019172:Transplantation Conditioning / Q000379:methods; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D014740:Vidarabine; C024352:fludarabine; D008558:Melphalan